• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES TOTAL BILIRUBIN; DIAZO COLORIMETRY, BILIRUBIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES TOTAL BILIRUBIN; DIAZO COLORIMETRY, BILIRUBIN Back to Search Results
Model Number 6L45-42
Medical Device Problem Code Low Test Results (2458)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/09/2021
Type of Reportable Event Malfunction
Event or Problem Description
The customer obtained a falsely depressed architect total bilirubin result.On (b)(6) 2021 sample id (b)(6) generated 16.4 and repeat 117 umol/l.No impact to patient management was reported.
 
Additional Manufacturer Narrative
(b)(4).Was this device serviced by a third party? no.Patient information: no further information was provided.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event or Problem Description
The customer obtained a falsely depressed architect total bilirubin result.On (b)(6) 2021 sample id (b)(6) generated 16.4 and repeat 117 umol/l.No impact to patient management was reported.
 
Additional Manufacturer Narrative
It was discovered on april 21, 2021 that the initial emdr for this issue was submitted under the correct suspect medical device but incorrect manufacturer name, city and state.Mdr number 3002809144-2021-00282 has been submitted for the correct manufacturing site and all further information will be documented under that mdr number.H3 other text : refer to new mdr 3002809144-2021-00282 for device evaluation.
 
Additional Manufacturer Narrative
This follow up is submitted to populate fields d8 and/or h6 with data that had previously been provided in field h10.There is no change to the content of the data.H3 other text: refer to mdr 3002809144-2021-00282.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TOTAL BILIRUBIN
Common Device Name
DIAZO COLORIMETRY, BILIRUBIN
Manufacturer (Section D)
ABBOTT LABORATORIES
1915 hurd drive
irving TX 75038
MDR Report Key11694010
Report Number3016438761-2021-00151
Device Sequence Number3128119
Product Code CIG
UDI-Device Identifier00380740174972
UDI-Public00380740174972
Combination Product (Y/N)N
Initial Reporter CountryUK
PMA/510(K) Number
K121985
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source foreign,health professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 06/24/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number6L45-42
Device Catalogue Number06L45-42
Device Lot Number58020UQ08
Was Device Available for Evaluation? Yes
Initial Date Received by Manufacturer 04/09/2021
Supplement Date Received by Manufacturer04/21/2021
06/24/2021
Initial Report FDA Received Date04/20/2021
Supplement Report FDA Received Date04/30/2021
06/24/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ARC C16K PRC MOD, 03L77-01, C1600672; ARC C16K PRC MOD, 03L77-01, C1600672; ARC C16K PRC MOD, 03L77-01, C1600672
-
-